SynthesisEuropean journal of clinical pharmacology2017

Risk of gastrointestinal events with newly approved (after 2011) vascular endothelial growth factor receptor tyrosine kinase inhibitors in cancer patients: a meta-analysis of randomized controlled trials.

Jing Li et al.PubMed ↗Publisher ↗

No numbers read from the abstract.